Beyond the therapeutic shackles of the monoamines: New mechanisms in bipolar disorder biology

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  2017-01-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pnpbp.2016.09.004PMID 27616052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of long-term lithium treatment of bipolar disorder on stem cells circulating in peripheral blood

  2017cited by this paper
• Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression

  2016cited by this paper
• NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  2016cited by this paper
• The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis.

  2015cited by this paper
• Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder.

  2015cited by this paper
• The inflammatory cytokines: molecular biomarkers for major depressive disorder?

  2015cited by this paper
• Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent.

  2015cited by this paper
• The role of brain‐derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case–control study, comorbidities, and meta‐analysis of 16,786 subjects

  2015cited by this paper
• A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability.

  2015cited by this paper
• Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder.

  2015cited by this paper
• Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.

  2015cited by this paper
• Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients.

  2014cited by this paper
• Single Ketamine Infusion and Neurocognitive Performance in Bipolar Depression

  2014cited by this paper
• Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder.

  2014cited by this paper
• Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass

  2014cited by this paper
• Staging bipolar disorder: clinical, biochemical, and functional correlates

  2014cited by this paper
• Plasma fibrinogen: now also an antidepressant response marker?

  2014cited by this paper
• Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration

  2014cited by this paper
• An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.

  2014cited by this paper
• Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study.

  2014cited by this paper
• Increased platelet intracellular calcium ion concentration is specific to bipolar disorder.

  2014cited by this paper
• Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.

  2014cited by this paper
• Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels

  2014cited by this paper
• [Factors connected with efficacy of single ketamine infusion in bipolar depression].

  2014cited by this paper
• The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment.

  2014cited by this paper
• Memantine in the management of affective recurrences of bipolar disorders after the discontinuation of long-term lithium treatment: three case histories

  2014cited by this paper
• Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

  2014cited by this paper
• An updated meta-analysis of oxidative stress markers in bipolar disorder.

  2014cited by this paper
• The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

  2013cited by this paper
• Risky alcohol use in young persons with emerging bipolar disorder is associated with increased oxidative stress.

  2013cited by this paper
• Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.

  2013cited by this paper
• Vitamin B12 Level may be Related to the Efficacy of Single Ketamine Infusion in Bipolar Depression

  2013cited by this paper
• So depression is an inflammatory disease, but where does the inflammation come from?

  2013cited by this paper
• A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.

  2013cited by this paper
• Excitotoxicity: bridge to various triggers in neurodegenerative disorders.

  2013cited by this paper
• Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder

  2013cited by this paper
• Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies.

  2013cited by this paper
• Putative neuroprotective agents in neuropsychiatric disorders.

  2013cited by this paper
• Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?

  2013cited by this paper
• Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

  2013cited by this paper
• In vivo glutathione levels in young persons with bipolar disorder: a magnetic resonance spectroscopy study.

  2013cited by this paper
• TNF-α signalling and inflammation: interactions between old acquaintances

  2013cited by this paper
• Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction.

  2013cited by this paper
• Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.

  2013cited by this paper
• Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) Gene Associated with Treatment Response to Mood Stabilizers in Patients with Bipolar I Disorder

  2013cited by this paper
• The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder

  2013cited by this paper
• A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

  2013cited by this paper
• Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application

  2013cited by this paper
• Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.

  2013cited by this paper
• Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development

  2013cited by this paper
• Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations.

  2012cited by this paper
• Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.

  2012cited by this paper
• Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.

  2012cited by this paper
• Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study.

  2012cited by this paper
• Platelet uptake of GABA and glutamate in patients with bipolar disorder.

  2012cited by this paper
• From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

  2012cited by this paper
• Aripiprazole altered plasma levels of brain‐derived neurotrophic factor and catecholamine metabolites in first‐episode untreated Japanese schizophrenia patients

  2012cited by this paper
• Minocycline: therapeutic potential in psychiatry.

  2012cited by this paper
• Mitochondrial Mutations and Polymorphisms in Psychiatric Disorders

  2012cited by this paper
• Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients

  2012cited by this paper
• Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.

  2012cited by this paper
• Quetiapine for bipolar depression: a systematic review and meta-analysis

  2012cited by this paper
• Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.

  2012cited by this paper
• Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: an open-label trial in drug-free patients with bipolar disorder.

  2012cited by this paper
• RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

  2012cited by this paper
• Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.

  2012cited by this paper
• Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial

  2012cited by this paper
• Evidence for an association between tumor necrosis factor-alpha levels and lithium response.

  2012cited by this paper
• Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

  2012cited by this paper
• Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder.

  2012cited by this paper
• Novel glutamatergic agents for major depressive disorder and bipolar disorder.

  2012cited by this paper
• Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

  2012cited by this paper
• Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta‐analysis

  2012cited by this paper
• Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.

  2011cited by this paper
• Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system

  2011cited by this paper
• Impact of antipsychotics on cytokine production in-vitro.

  2011cited by this paper
• Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance.

  2011cited by this paper
• Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder.

  2011cited by this paper
• Antipsychotic medication and oxidative cell stress: a systematic review.

  2011cited by this paper
• Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.

  2011cited by this paper
• Peripheral biomarkers and illness activity in bipolar disorder.

  2011cited by this paper
• Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.

  2011cited by this paper
• Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.

  2011cited by this paper
• Effects of lithium on oxidative stress parameters in healthy subjects.

  2011cited by this paper
• Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia.

  2011cited by this paper
• Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

  2011cited by this paper
• Case–case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes

  2011cited by this paper
• The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

  2011cited by this paper
• Inflammation, mitochondria, and the inhibition of adult neurogenesis

  2011cited by this paper
• Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment

  2011cited by this paper
• Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

  2011cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• ole of pro-inflammatory cytokines released from microglia in eurodegenerative diseases

  2011cited by this paper
• Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study.

  2011cited by this paper
• Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.

  2010cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• From neuroprogression to neuroprotection: implications for clinical care.

  2010cited by this paper
• Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

  2010cited by this paper
• Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

  2010cited by this paper
• eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors

  2010cited by this paper

• Mood Stabilizers (Lamotrigine, Lithium, and Valproic Acid) Decrease Bipolar Disease Model (Ouabain)‐Induced Oxidative Stress and Apoptosis Through the Inhibition of the TRPM2 Channel in Neuronal Cells

  2025cites this paper
• Mitochondrial Insights into Lithium Response in Bipolar Disorder: A State-of-the-Art Review.

  2025cites this paper
• Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review

  2024cites this paper
• Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine

  2023cites this paper
• Nutritional interventions for the prevention and treatment of neurological disorders such as anxiety, bipolar disorder, depression, epilepsy, multiple sclerosis, and schizophrenia

  2022cites this paper
• Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder

  2022cites this paper
• Targeting Mitochondrial Dysfunction for Bipolar Disorder.

  2021cites this paper
• The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials

  2021cites this paper
• Effects of tamoxifen and glutamate and glutamine levels in brain regions in repeated sleep deprivation–induced mania model in mice

  2020cites this paper
• Inflammation in Bipolar Disorder (BD): Identification of New Therapeutic Targets.

  2020cites this paper
• Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis

  2020cites this paper
• The black sheep of the family- whole-exome sequencing in family of lithium response discordant bipolar monozygotic twins.

  2020cites this paper
• Bipolar Spectrum

  2019cites this paper
• The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia

  2019influential citation
• Current Role of Herbal and Natural Preparations.

  2019cites this paper
• Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

  2019cites this paper
• Diet quality, dietary inflammatory index and body composition as predictors of N-acetylcysteine and mitochondrial agents efficacy in bipolar disorder

  2019cites this paper
• Inflamação na Doença Bipolar: Identificação de Novos Alvos Terapêuticos

  2019cites this paper
• Transcriptomic evidence for dense peptidergic neuromodulation networks in mouse cortex

  2019cites this paper
• Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review

  2019cites this paper
• the Movement Towards Personalized Medicine: Pharmacogenomics for Diagnosis and Treatment in Mood Disroders

  2019cites this paper
• Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial

  2019cites this paper
• Single-cell transcriptomic evidence for dense intracortical neuropeptide networks

  2019cites this paper
• Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats

  2019cites this paper
• Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders

  2019cites this paper
• An update on adjunctive treatment options for bipolar disorder

  2018cites this paper
• Association between CRP genetic diversity and bipolar disorder comorbid complications

  2018cites this paper
• Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

  2018cites this paper
• In the Realm of Psychoneuroimmunology: The Role of Celecoxib as an Add-On Treatment for Bipolar Mania

  2018cites this paper
• FREE AND ZEOLITE-IMMOBILIZED PROBIOTIC MIXTURE VERSUS SODIUM VALPROATE IN PREVENTION OF OXIDATIVE STRESS AND MODULATION OF THE L-ARGININE INTRACELLULAR METABOLIC PATHWAYS IN THE RAT BRAIN AND BLOOD FOLLOWING DEXAMPHETAMINE-INDUCED BIPOLAR D

  2018cites this paper
• Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse

  2017cites this paper
• Biological hypotheses and biomarkers of bipolar disorder

  2017cites this paper
• Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges

  2017influential citation
• The ups and downs of cellular stress : the “ MAM hypothesis ” for Bipolar disorder pathophysiology REVIEW

  2017cites this paper
• Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.

  2017cites this paper
• Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature

  2017cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM PSIQUIATRIA E CIÊNCIAS DO COMPORTAMENTO

  2016cites this paper